U.S. Immigration and Customs Enforcement (ICE) has responded after a video shared widely on social media showed agents taking ...
Axsome Therapeutics has wrapped its hands around an epilepsy candidate from AstraZeneca through an acquisition of Avenue ...
Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulatorDeepens Axsome’s broad ...
Robot-guided neurosurgery in patients with epilepsy involves accurately mapping the skull to identify the entry points and target areas. A recent study compared the clinical utility of a contactless ...
EMA’s PRIME designation bolsters Neurona’s global development strategy and underscores the company’s commitment to bringing NRTX-1001 interneuron cell therapy to patients worldwide.
"Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults," the authors wrote. "The bidirectional associations we observed suggest ...
Health Canada confirmed Tuesday that it seized a range of unauthorized health products from a Kelowna business, including ...
For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be ...
In today’s Health Headlines, can treatment-resistant epilepsy improve over time? Are melatonin supplements bad for your heart ...
Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay ...
And they feel lucky. The waitlist for treatment is three months long and ever-growing, according to Shriti Patel, who ...
Electroconvulsive therapy is a safe, effective treatment for severe psychiatric conditions like suicidal depression, catatonia, and resistant mania. It induces controlled seizures under anaesthesia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback